Log In
BCIQ
Print this Print this
 

NmVac4

  Manage Alerts
Collapse Summary General Information
Company JN-International Medical Corp.
DescriptionMeningococcal (groups A, C, Y, W-135) polysaccharide diphtheria toxoid conjugate vaccine
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationMeningitis
Indication DetailsPrevent meningitis from groups A,C,Y and W-135 meningococcal infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today